P

ProPhase Labs
D

PRPH

0.72400
USD
-0.03
(-3.47%)
Market Open
Volume
300
EPS
-1
Div Yield
-
P/E
-0
Market Cap
17,284,797
Related Instruments
    A
    AKTX
    -0.32000
    (-13.56%)
    2.04000 USD
    C
    CRMD
    -0.660
    (-6.00%)
    10.340 USD
    E
    EYPT
    -1.31000
    (-12.50%)
    9.17000 USD
    I
    INFI
    -0.046100
    (-55.54%)
    0.036900 USD
    M
    MDGL
    -13.55
    (-4.48%)
    288.99 USD
    N
    NBRV
    0.04000
    (2.84%)
    1.45000 USD
    T
    TVTX
    -0.720
    (-3.90%)
    17.740 USD
    More
News

Title: ProPhase Labs

Sector: Healthcare
Industry: Diagnostics & Research
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research,development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.